Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
2.980
-0.160 (-5.06%)
Mar 31, 2025, 2:11 PM EDT - Market open

Artiva Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-65.37-28.72-58.79-71.83-17.99
Upgrade
Depreciation & Amortization
2.432.271.160.250.07
Upgrade
Other Amortization
--4.08--
Upgrade
Loss (Gain) From Sale of Investments
-2.34-0.46---
Upgrade
Stock-Based Compensation
6.987.056.584.310.3
Upgrade
Other Operating Activities
3.60.71-18.55-0.28
Upgrade
Change in Accounts Receivable
1.03-0.51-0.06-0.47-
Upgrade
Change in Accounts Payable
0.52-0.410.19-1.241.82
Upgrade
Change in Unearned Revenue
--26.53-2.4528.97-
Upgrade
Change in Other Net Operating Assets
-1.88-0.84-1.556.152.54
Upgrade
Operating Cash Flow
-55.03-47.43-50.83-15.3-13.54
Upgrade
Capital Expenditures
-0.64-3.26-6.3-1.72-0.28
Upgrade
Investment in Securities
-119.82-22.72---
Upgrade
Investing Cash Flow
-120.46-25.98-6.3-1.72-0.28
Upgrade
Long-Term Debt Issued
----3
Upgrade
Total Debt Issued
----3
Upgrade
Long-Term Debt Repaid
-0.15----
Upgrade
Net Debt Issued (Repaid)
-0.15---3
Upgrade
Issuance of Common Stock
166.560.010.330.180.22
Upgrade
Repurchase of Common Stock
--0.01-0.01--
Upgrade
Other Financing Activities
-4.1824.39-1.59-2.03-0.46
Upgrade
Financing Cash Flow
162.2324.39-1.26152.7537.4
Upgrade
Net Cash Flow
-13.27-49.01-58.39135.7323.57
Upgrade
Free Cash Flow
-55.67-50.69-57.13-17.03-13.83
Upgrade
Free Cash Flow Margin
-22180.88%-151.34%-1158.55%-850.55%-
Upgrade
Free Cash Flow Per Share
-4.95-63.14-74.51-24.83-21.89
Upgrade
Cash Income Tax Paid
-0.08---
Upgrade
Levered Free Cash Flow
-33.75-27.32-29.38-17.6-7.46
Upgrade
Unlevered Free Cash Flow
-33.75-27.32-29.38-17.6-7.33
Upgrade
Change in Net Working Capital
0.4714.21-2.49-12.87-4
Upgrade
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q